Time-dependent increased risk for serious infection from continuous use of TNF antagonists during three years in rheumatoid arthritis patients
Arthritis Care & Research ,

Sakai R et al. – Continuous anti–tumor necrosis factor (TNF) therapy was significantly associated with increased risks for developing serious infections (SIs) during, but not after, the first year.

Methods
  • The authors analyzed 727 RA patients who had started either infliximab (IFX) or etanercept (ETN) [the anti–TNF group, 1480.1 patient–years (PY)] and 571 RA patients who had started conventional non–biological DMARDs (the unexposed group, 1104.1 PY) at the time of enrollment in REAL.
  • They assessed the occurrence of SIs within a three–year observation period, including the period after switching to other TNF antagonists and all SIs, unlimited to the first one in each patient as reported in other studies, to evaluate the real safety of TNF antagonists in daily practice.

Results
  • The incidence rate of SIs per 100 PY was 5.54 (95% confidence interval [95% CI] 4.44–6.84) in the anti–TNF group and 2.72 (95% CI, 1.87–3.83) in the unexposed group.
  • Poisson regression analysis revealed that the relative risk (RR; 95% CI) of continuous use of TNF antagonists for SIs after adjusting for baseline and time–dependent covariates was significantly elevated both for overall [1.97(1.25–3.19)] and for the first year [2.40 (1.20–5.03)], but not for the second and third years combined [1.38 (0.80–2.43)].
  • The adjusted RR for SIs of ETN compared to IFX was not significantly elevated.

Please login or register to follow this author.
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

    Currently, there are no available articles.

Your Unread Messages in Internal Medicine

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Internal Medicine Articles

Indexed Journals in Internal Medicine: New England Journal of Medicine, The Lancet, Archives of Internal Medicinemore

Make smarter career moves with less time.

Sign up for our free job placement service today and have a dedicated career consultant help locate the right physician job for you!
Click Here for more information.

Get Started Now!

Free-of-charge, no obligation.

Terms and Conditions For M3 Career Consult

By registering with the M3 Career Consult service you authorize M3 USA Corporation to represent you in your job search. The following is a summary of the terms of our service and our mutual obligations to help you find a job:

  • You designate M3 to act as your agent and represent you in your job search;
  • You will not pay us for this service
  • You will advise us of any companies or positions to which you apply or have applied;
  • You will advise us if you believe you are not capable of performing a position for which we submit you, or for which you interview;
  • You will keep all information we provide you about companies or positions strictly confidential;
  • You will promptly provide us with information we request of you;
  • You will make yourself reasonably available for phone, video and in-person conversations and interviews;
  • You will be truthful in all of your communications with us; and
  • You will advise us if anything above changes.
 

The Top Read Articles of 2014 are Now Available

Scouring thousands of peer-reviewed journals and popular press, Our Editors just released the Top Read Articles of the Year. See the Top Read List